These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28919541)

  • 1. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K; Sivaramakrishnan G
    J Pain Symptom Manage; 2018 Feb; 55(2):468-479.e1. PubMed ID: 28919541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA; Sheridan EA
    Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Management of Opioid-Induced Constipation in Cancer and Advanced Illness: A Meta-Analysis.
    Jesuyajolu DA; Abubakar AK; Kowe T; Ogunlade S; Abioye AI; Tangeman J; Latuga N; Omotayo MO
    J Pain Symptom Manage; 2024 Apr; 67(4):e285-e297. PubMed ID: 38092261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
    Nalamachu SR; Pergolizzi J; Taylor R; Slatkin NE; Barrett AC; Yu J; Bortey E; Paterson C; Forbes WP
    Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC; Brenner DM; Schoenfeld PS
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer.
    Katakami N; Oda K; Tauchi K; Nakata K; Shinozaki K; Yokota T; Suzuki Y; Narabayashi M; Boku N
    J Clin Oncol; 2017 Jun; 35(17):1921-1928. PubMed ID: 28445097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
    Candy B; Jones L; Goodman ML; Drake R; Tookman A
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
    Esmadi M; Ahmad D; Hewlett A
    J Gastrointestin Liver Dis; 2019 Mar; 28(1):41-46. PubMed ID: 30851171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of naldemedine for the treatment of opioid-induced constipation.
    Song X; Wang D; Qu X; Dong N; Teng S
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):121-128. PubMed ID: 30652502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R; Li Z; Huang S; Liu J; Huang J
    Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naldemedine: First Global Approval.
    Markham A
    Drugs; 2017 May; 77(8):923-927. PubMed ID: 28466424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
    Nusrat S; Syed T; Saleem R; Clifton S; Bielefeldt K
    Dig Dis Sci; 2019 Jan; 64(1):39-49. PubMed ID: 30284134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Options in Constipation Management.
    Davis M; Gamier P
    Curr Oncol Rep; 2015 Dec; 17(12):55. PubMed ID: 26449843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.
    Webster LR; Nalamachu S; Morlion B; Reddy J; Baba Y; Yamada T; Arjona Ferreira JC
    Pain; 2018 May; 159(5):987-994. PubMed ID: 29419653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.